Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2

In Epstein-Barr virus (EBV) latent infection, the EBV-encoded RNAs EBER1 and EBER2 accumulate in the host cell nucleus to ~106 copies. While the expression of EBERs in cell lines is associated with transformation, a mechanistic explanation of their roles in EBV latency remains elusive. To identify EBER-specific gene expression features, we compared the proteome and mRNA transcriptome from BJAB cells (an EBV-negative B lymphoma cell line) stably transfected with an empty plasmid or with one carrying both EBER genes. We identified ~1800 proteins with at least 2 SILAC pair measurements, of which only 8 and 12 were up- and downregulated ≥ 2-fold, respectively. One upregulated protein was PIK3AP1, a B-cell specific protein adapter known to activate the PI3K-AKT signaling pathway, which regulates alternative splicing and translation in addition to its pro-survival effects. In the mRNA-seq data, the mRNA levels for some of the proteins changing in the SILAC data did not change. We instead observed isoform switch events. We validated the most relevant findings with biochemical assays. These corroborated the upregulation of PIK3AP1 and AKT activation in BJAB cells expressing high levels of both EBERs and EBNA1 (a surrogate of Burkitt’s lymphoma EBV latency I) relative to those expressing only EBNA1. The mRNA-seq data in these cells showed multiple upregulated oncogenes whose mRNAs are enriched for 3´-UTR AU-rich elements (AREs), such as ccl3, ccr7, il10, vegfa and zeb1. The CCL3, CCR7, IL10 and VEGFA proteins promote cell proliferation and are associated with EBV-mediated lymphomas. In EBV latency, ZEB1 represses the transcription of ZEBRA, an EBV lytic phase activation factor. We previously found that EBER1 interacts with AUF1 in vivo and proposed stabilization of ARE-containing mRNAs. Thus, the ~106 copies of EBER1 may promote not only cell proliferation due to an increase in the levels of ARE-containing genes like ccl3, ccr7, il10, and vegfa, but also the maintenance of latency, through higher levels of zeb1.

[1]  Gary D Bader,et al.  A draft map of the human proteome , 2014, Nature.

[2]  J. Wilusz,et al.  Cytoplasmic Viruses: Rage against the (Cellular RNA Decay) Machine , 2013, PLoS pathogens.

[3]  N. Chiorazzi,et al.  B cell receptor signaling in chronic lymphocytic leukemia. , 2013, Trends in immunology.

[4]  M. Garcia-Blanco,et al.  Epstein-Barr Virus Induces Global Changes in Cellular mRNA Isoform Usage That Are Important for the Maintenance of Latency , 2013, Journal of Virology.

[5]  H. Prats,et al.  VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level , 2013, Nucleic acids research.

[6]  J. Steitz,et al.  AUF1/hnRNP D is a novel protein partner of the EBER1 noncoding RNA of Epstein-Barr virus. , 2012, RNA.

[7]  R. Hassan,et al.  Relationship of Epstein-Barr Virus and Interleukin 10 Promoter Polymorphisms with the Risk and Clinical Outcome of Childhood Burkitt Lymphoma , 2012, PloS one.

[8]  J. Mertz,et al.  Shutoff of BZLF1 Gene Expression Is Necessary for Immortalization of Primary B Cells by Epstein-Barr Virus , 2012, Journal of Virology.

[9]  R. Robey,et al.  AUF1/hnRNP D represses expression of VEGF in macrophages , 2012, Molecular biology of the cell.

[10]  Jin Billy Li,et al.  Accurate identification of human Alu and non-Alu RNA editing sites , 2012, Nature Methods.

[11]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[12]  M. Rapé,et al.  Regulation of ubiquitin chain initiation to control the timing of substrate degradation. , 2011, Molecular cell.

[13]  Cole Trapnell,et al.  Computational methods for transcriptome annotation and quantification using RNA-seq , 2011, Nature Methods.

[14]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[15]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[16]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[17]  Robert E. White,et al.  Cellular Gene Expression That Correlates with EBER Expression in Epstein-Barr Virus-Infected Lymphoblastoid Cell Lines , 2011, Journal of Virology.

[18]  S. Pestka,et al.  RNA-Binding Protein AUF1 Regulates Lipopolysaccharide-Induced IL10 Expression by Activating IκB Kinase Complex in Monocytes , 2010, Molecular and Cellular Biology.

[19]  P. Moore,et al.  Why do viruses cause cancer? Highlights of the first century of human tumour virology , 2010, Nature Reviews Cancer.

[20]  D. Ganem,et al.  Viral latency and its regulation: lessons from the gamma-herpesviruses. , 2010, Cell host & microbe.

[21]  S. Ishikawa,et al.  Downregulation of microRNA-200 in EBV-associated gastric carcinoma. , 2010, Cancer research.

[22]  M. Jantsch,et al.  Proteome diversification by adenosine to inosine RNA-editing , 2010, RNA biology.

[23]  K. Takada,et al.  Modulation of innate immunity system by Epstein–Barr virus‐encoded non‐coding RNA and oncogenesis , 2010, Cancer science.

[24]  M. Gerstein,et al.  EBNA1 regulates cellular gene expression by binding cellular promoters , 2009, Proceedings of the National Academy of Sciences.

[25]  I. K. Ruf,et al.  Growth-Promoting Properties of Epstein-Barr Virus EBER-1 RNA Correlate with Ribosomal Protein L22 Binding , 2009, Journal of Virology.

[26]  D. Thorley-Lawson,et al.  The curious case of the tumour virus: 50 years of Burkitt's lymphoma , 2008, Nature Reviews Microbiology.

[27]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[28]  Anason S. Halees,et al.  ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse , 2007, Nucleic Acids Res..

[29]  T. Kanda,et al.  Epstein-Barr Virus (EBV)-Encoded RNA 2 (EBER2) but Not EBER1 Plays a Critical Role in EBV-Induced B-Cell Growth Transformation , 2007, Journal of Virology.

[30]  R. Davis Fc receptor-like molecules. , 2007, Annual review of immunology.

[31]  J. Steitz,et al.  Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling , 2006, The Journal of cell biology.

[32]  J. Steitz,et al.  Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22. , 2006, RNA.

[33]  B. Graveley Coordinated control of splicing and translation , 2005, Nature Structural &Molecular Biology.

[34]  D. Stevenson,et al.  Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. , 2005, Cancer research.

[35]  M. Colonna,et al.  A new Fc receptor homolog, FREB2, found in germinal center B cells , 2005, Genes and Immunity.

[36]  T. Kanda,et al.  Critical Role of Epstein-Barr Virus (EBV)-Encoded RNA in Efficient EBV-Induced B-Lymphocyte Growth Transformation , 2005, Journal of Virology.

[37]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[38]  M. Hentze,et al.  Molecular mechanisms of translational control , 2004, Nature Reviews Molecular Cell Biology.

[39]  B. Damania Oncogenic γ-herpesviruses: comparison of viral proteins involved in tumorigenesis , 2004, Nature Reviews Microbiology.

[40]  E. Birney,et al.  The International Protein Index: An integrated database for proteomics experiments , 2004, Proteomics.

[41]  D. Fremont,et al.  An unusual Fc receptor-related protein expressed in human centroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Naoe,et al.  Epstein–Barr virus‐encoded poly(A)− RNA supports Burkitt's lymphoma growth through interleukin‐10 induction , 2000, The EMBO journal.

[43]  T. Kurosaki,et al.  BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. , 2000, Immunity.

[44]  Y. Iwanaga,et al.  Malignant transformation of B lymphoma cell line BJAB by Epstein–Barr virus‐encoded small RNAs , 2000, FEBS letters.

[45]  J. Sample,et al.  Epstein-Barr Virus Small RNAs Potentiate Tumorigenicity of Burkitt Lymphoma Cells Independently of an Effect on Apoptosis , 2000, Journal of Virology.

[46]  E. Kieff,et al.  Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors , 1993, Journal of virology.

[47]  E. Kieff,et al.  Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Shu,et al.  Epstein-Barr virus small RNA (EBER) genes: Unique transcription units that combine RNA polymerase II and III promoter elements , 1989, Cell.

[49]  J. Steitz,et al.  Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells , 1988, Journal of virology.

[50]  J. Steitz,et al.  Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII , 1981, Molecular and cellular biology.

[51]  J. Steitz,et al.  Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Ruedi Aebersold,et al.  Comprehensive proteomics. , 2011, Current opinion in biotechnology.

[53]  K. Takada,et al.  Role of EBERs in the pathogenesis of EBV infection. , 2010, Advances in cancer research.

[54]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[55]  B. Damania Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis. , 2004, Nature reviews. Microbiology.

[56]  B. Alabyev,et al.  FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features. , 2002, European journal of immunology.